Generic Name: Ibuprofen
Drug Class: Nonsteroidal Anti-inflammatory Drug (NSAID)
Therapeutic Class: Antipyretic, analgesic, anti-inflammatory
Pediatric Formulations: Oral suspension, chewable tablets, suppositories (in some markets)
Common Pediatric Brand Names: Nurofen for Children, Advil Children’s, Motrin Children’s, Brufen Pediatric
Mechanism of Action
Ibuprofen is a non-selective cyclooxygenase (COX) inhibitor. It inhibits both COX-1 and COX-2 isoenzymes, thereby reducing the synthesis of prostaglandins involved in pain, fever, and inflammation. In children, ibuprofen exerts:
-
Antipyretic effects: Acts on the hypothalamic thermoregulatory center to reduce fever
-
Analgesic effects: Decreases pain from inflammation or tissue damage
-
Anti-inflammatory effects: Alleviates inflammation in soft tissue, joints, or post-surgical conditions
Approved Pediatric Indications
-
Fever (Antipyresis):
-
Used to reduce temperature in febrile children, including fever caused by infections or post-vaccination reactions.
-
-
Mild to Moderate Pain:
-
Effective for pain associated with sore throat, toothache, earache, musculoskeletal injuries, headache, and postoperative pain.
-
-
Inflammatory Conditions (Off-label in some countries):
-
Juvenile idiopathic arthritis (JIA)
-
Minor soft tissue injuries
-
-
Post-Immunization Reactions:
-
Reduces fever and discomfort following vaccinations.
-
Age Recommendations and Dosing
General Pediatric Use:
-
Approved for children ≥3 months of age and ≥5–6 kg body weight (region-dependent regulatory status applies).
-
Dosing based on weight:
5–10 mg/kg/dose every 6–8 hours as needed-
Maximum: 30–40 mg/kg/day (not to exceed 2400 mg/day in adolescents)
-
Age-Specific Guidelines (common UK/US recommendations):
Age | Single Dose | Frequency |
---|---|---|
3–5 months | 50 mg | Every 6–8 h, max 3 doses/day |
6–11 months | 50 mg | Every 6–8 h |
1–3 years | 100 mg | Every 6–8 h |
4–6 years | 150 mg | Every 6–8 h |
7–9 years | 200 mg | Every 6–8 h |
10–12 years | 250–300 mg | Every 6–8 h |
>12 years | Adult dose (200–400 mg) | Every 6–8 h |
Formulations for Children
-
Oral Suspension:
-
Most commonly used in children under 12
-
Strengths: 100 mg/5 mL or 200 mg/5 mL
-
Syringe or spoon provided for precise dosing
-
-
Chewable Tablets or Meltlets:
-
Suitable for older children who can chew/swallow solid forms
-
Strengths: Typically 100 mg or 200 mg per tablet
-
-
Suppositories (varies by country):
-
Used when oral route is not feasible (vomiting, NPO status)
-
-
Effervescent Granules (available in some formulations):
-
Dissolvable in water for children with swallowing difficulties
-
Contraindications in Children
-
Known hypersensitivity to ibuprofen or other NSAIDs
-
History of aspirin-sensitive asthma or NSAID-induced urticaria
-
Active gastrointestinal bleeding or peptic ulceration
-
Severe hepatic or renal impairment
-
Dehydration due to vomiting/diarrhea (increased risk of renal toxicity)
-
Congenital bleeding disorders or ongoing anticoagulant therapy
Cautions and Special Precautions
-
Asthma: May exacerbate bronchospasm in aspirin-sensitive individuals
-
Renal Impairment: Ibuprofen reduces renal perfusion in volume-depleted states
-
Dehydration: Increases risk of nephrotoxicity; avoid during acute gastroenteritis
-
Chickenpox (Varicella): Rare but serious skin infections (necrotizing fasciitis) reported with NSAID use; some guidelines advise against use
-
Long-term use: Should be avoided unless under specialist guidance (e.g., juvenile arthritis)
Adverse Effects
Common:
-
Gastrointestinal discomfort, nausea, vomiting
-
Diarrhea or constipation
-
Headache or dizziness
-
Rash
Less Common to Rare:
-
Gastritis, GI bleeding, ulceration
-
Bronchospasm (especially in asthmatic children)
-
Hypersensitivity reactions: urticaria, angioedema
-
Renal impairment or acute kidney injury (especially with dehydration)
-
Elevated liver enzymes (rare)
Severe (Rare):
-
Stevens-Johnson syndrome
-
Toxic epidermal necrolysis
-
Anaphylaxis
-
Aseptic meningitis
Drug Interactions
Avoid co-administration or monitor closely with:
-
Other NSAIDs: Increased GI and renal toxicity
-
Aspirin: Antagonizes cardioprotective effect of low-dose aspirin
-
Corticosteroids: Increased risk of GI ulceration
-
Anticoagulants (e.g., warfarin): Increased bleeding risk
-
Antihypertensives (ACE inhibitors, ARBs, diuretics): Decreased efficacy and increased renal risk
-
Methotrexate: Increased risk of methotrexate toxicity
-
SSRIs: Increased risk of gastrointestinal bleeding
-
Lithium: Decreased renal clearance and potential lithium toxicity
Overdose in Children
Symptoms:
-
Nausea, vomiting, abdominal pain
-
Drowsiness, dizziness
-
Ataxia, headache
-
Tinnitus
-
Rarely: metabolic acidosis, seizures, renal failure
Management:
-
Supportive care
-
Activated charcoal if ingestion is recent and >200 mg/kg
-
IV fluids and monitoring of renal function and acid-base status
-
Hospitalization if dose exceeds 400 mg/kg or if symptomatic
Comparison with Paracetamol (Acetaminophen)
Feature | Ibuprofen | Paracetamol |
---|---|---|
Action | Antipyretic, analgesic, anti-inflammatory | Antipyretic, analgesic |
Onset | 30–60 min | 30–60 min |
Duration | 6–8 hours | 4–6 hours |
Age | ≥3 months | ≥2 months |
GI effects | Higher risk | Minimal |
Liver toxicity | Rare | Dose-dependent, common in overdose |
Anti-inflammatory | Yes | No |
Patient Counseling for Parents and Caregivers
-
Dosing: Use proper measuring devices, never household spoons
-
Timing: Space doses at least 6 hours apart
-
Duration: Do not exceed 3 days for fever or 5 days for pain without medical review
-
Hydration: Ensure adequate fluid intake, especially during fever
-
Storage: Keep out of reach of children, store at room temperature
-
Allergic signs: Watch for rash, wheezing, or swelling; discontinue and seek medical help
-
Avoid in dehydration: If child has persistent vomiting/diarrhea, ibuprofen may not be appropriate
Clinical Efficacy
Numerous randomized trials confirm that ibuprofen is:
-
More effective than paracetamol in reducing high fever
-
Equally effective or superior for relief of mild to moderate pain (e.g., dental, ear, musculoskeletal)
-
Safe in short-term use when given at appropriate doses and under proper monitoring
-
Not recommended for routine use in febrile children solely to reduce temperature without discomfort
Regulatory and Global Guidance
-
UK (BNFc): Licensed from 3 months and ≥5 kg
-
US (FDA): OTC use in children ≥6 months
-
WHO Essential Medicines List (Children): Included for antipyretic and analgesic indications
-
EMA/European guidelines: Support use with standard precautions and dosing
Storage and Stability
-
Oral suspensions should be stored below 25°C
-
Discard any remaining suspension after 6 months of opening (unless specified otherwise)
-
Check expiry before use; do not freeze liquid forms
No comments:
Post a Comment